EU’s Innovation Catalyst Sets Out Cardiology And Biomarker Opportunities
Draft topics for funding in the next two rounds of the EU’s Innovative Health Initiative present more opportunities for the medtech sector to combine forces in cross-sector R&I.
You may also be interested in...
The EU Innovative Health Initiative will soon open its doors for the latest round of applicants, with up to €40 million ($44m) available in funding for each project. But who is eligible to apply for the scheme, and where do the key opportunities for medtech lie?
April will see the first call for proposals under the Innovative Health Initiative, a patient-centric, demand-led project that is about to come to life for technology innovators after 30 months of negotiations and preparations by European health care industry associations and the European Commission.
There is a much-acknowledged urgency to ensure medtech products are certified as fast as possible, with fears persisting that delays will result in notified body bottlenecks and product shortages.